Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

17,298 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
STAT3 polymorphism predicts interferon-alfa response in patients with metastatic renal cell carcinoma.
Ito N, Eto M, Nakamura E, Takahashi A, Tsukamoto T, Toma H, Nakazawa H, Hirao Y, Uemura H, Kagawa S, Kanayama H, Nose Y, Kinukawa N, Nakamura T, Jinnai N, Seki T, Takamatsu M, Masui Y, Naito S, Ogawa O. Ito N, et al. Among authors: nakamura e, nakamura t. J Clin Oncol. 2007 Jul 1;25(19):2785-91. doi: 10.1200/JCO.2006.09.8897. J Clin Oncol. 2007. PMID: 17602083
STAT3 polymorphism can predict the response to interferon-α therapy in patients with metastatic renal cell carcinoma.
Eto M, Kamba T, Miyake H, Fujisawa M, Kamai T, Uemura H, Tsukamoto T, Azuma H, Matsubara A, Nishimura K, Nakamura T, Ogawa O, Naito S; Japan Immunotherapy SNPs-Study Group for Kidney Cancer. Eto M, et al. Among authors: nakamura t. Eur Urol. 2013 Apr;63(4):745-52. doi: 10.1016/j.eururo.2012.09.052. Epub 2012 Sep 28. Eur Urol. 2013. PMID: 23063454 Clinical Trial.
Prognosis of metastatic renal cell carcinoma with first-line interferon-α therapy in the era of molecular-targeted therapy.
Kawano Y, Takahashi W, Eto M, Kamba T, Miyake H, Fujisawa M, Kamai T, Uemura H, Tsukamoto T, Azuma H, Matsubara A, Nishimura K, Nakamura T, Ogawa O, Naito S. Kawano Y, et al. Among authors: nakamura t. Cancer Sci. 2016 Jul;107(7):1013-7. doi: 10.1111/cas.12951. Epub 2016 Jun 14. Cancer Sci. 2016. PMID: 27089226 Free PMC article. Clinical Trial.
Randomized Controlled Study of the Efficacy, Safety and Quality of Life with Low Dose bacillus Calmette-Guérin Instillation Therapy for Nonmuscle Invasive Bladder Cancer.
Yokomizo A, Kanimoto Y, Okamura T, Ozono S, Koga H, Iwamura M, Tanaka H, Takahashi S, Tsushima T, Kanayama HO, Akaza H, Shinohara N, Mugiya S, Nomata K, Nakamura T, Naito S. Yokomizo A, et al. Among authors: nakamura t. J Urol. 2016 Jan;195(1):41-6. doi: 10.1016/j.juro.2015.08.075. Epub 2015 Aug 22. J Urol. 2016. PMID: 26307162 Clinical Trial.
Impact of Workplace on the Risk of Severe COVID-19.
Nakamura T, Mori H, Saunders T, Chishaki H, Nose Y. Nakamura T, et al. Front Public Health. 2022 Jan 5;9:731239. doi: 10.3389/fpubh.2021.731239. eCollection 2021. Front Public Health. 2022. PMID: 35071150 Free PMC article.
Cohort study for prevention of atopic dermatitis using hair mineral contents.
Yamada T, Saunders T, Kuroda S, Sera K, Nakamura T, Takatsuji T; Fukuoka College of Obstetricians and Gynecologists, Pediatric Association of Fukuoka District; Hara T, Nose Y. Yamada T, et al. Among authors: nakamura t. J Trace Elem Med Biol. 2013 Apr;27(2):126-31. doi: 10.1016/j.jtemb.2012.08.003. Epub 2012 Oct 24. J Trace Elem Med Biol. 2013. PMID: 23103056
17,298 results
You have reached the last available page of results. Please see the User Guide for more information.